JESSIE HEMRIC: Open Payments
NPI 1023650033 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$574 in 28 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $281 · 2025 $574
Food & beverage: $574
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $153 |
| GlaxoSmithKline, LLC. | 7 | $151 |
| AstraZeneca Pharmaceuticals LP | 4 | $73 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $46 |
| Lilly USA, LLC | 1 | $28 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $25 |
| Esperion Therapeutics, Inc. | 1 | $23 |
| Intercept Pharmaceuticals, Inc. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Amgen Inc. | 1 | $18 |
Products named: TRELEGY ELLIPTA, Ozempic, Kerendia, REXULTI, Rybelsus, BREZTRI, AIRSUPRA, KISUNLA.
Industry payments across FL — which companies pay providers there.
